| Term 
 
        | causes of nausea and vomiting in adults 10 |  | Definition 
 
        | metabolic neuro
 CV disorder
 GI disorder
 infection
 pregnancy
 operations
 drugs
 chemo
 emotions
 |  | 
        |  | 
        
        | Term 
 
        | causes of nausea and vomiting in kids 14 |  | Definition 
 
        | pyloric stenosis duodenal ulcer
 stress ulcer
 adrenal insufficiency
 septicemia
 disease of pancreas, liver, biliary tree
 GI obstruction
 increased ICP
 overfeeding
 rapid feeding
 inadequate burping
 laying down too soon after feeding
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | immediate need to vomit, gastric stasis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | rhythmic action of respiratory muscles (abdominal, inercostal, diaphragmatic) against closed glottis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | forceful expulsion of gastric contentents caused by GI retroperistalsis, salivation, shivering, vasomotor changes |  | 
        |  | 
        
        | Term 
 
        | afferent sensory nerves send receptors for nausea and vomiting to 3 |  | Definition 
 
        | chemoreceptor trigger zone (CTZ) cerebral cortex
 visceral afferents from pharynx and GI
 |  | 
        |  | 
        
        | Term 
 
        | afferent signals are intergrated by vomiting center in medulla and efferent impulses go to 5 |  | Definition 
 
        | salivation center respiratory center
 pharyngeal, GI, abdominal muscles
 |  | 
        |  | 
        
        | Term 
 
        | NT involved in vomiting center, CTZ, GI tract 4 |  | Definition 
 
        | ACH (M), histamine (H1), dopamine (D2), serotonin (5-HT3), opiate receptors |  | 
        |  | 
        
        | Term 
 
        | categories of drugs that help with nausea and vomiting 5 |  | Definition 
 
        | 5-HT3 antagonist dopamine antagonist
 antihistamine
 anticholinergics
 cannabis
 |  | 
        |  | 
        
        | Term 
 
        | 2 5-HT3 antagonists used in nausea and vomitin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 5 dopamine antagonist used in nausea and vomiting |  | Definition 
 
        | chlori was a pro, a pro at doing meth, a pro chlori was, she drop it like it hot on the metro, chlori pride chelrpromazine
 promethazine
 prochlorperazine
 deoperidol
 metoclopramide
 |  | 
        |  | 
        
        | Term 
 
        | 2 antihistamines used in nausea and vomiting and their administrations |  | Definition 
 
        | meclizine (oral) diphenhydramine (oral, IM, IV)
 |  | 
        |  | 
        
        | Term 
 
        | 1 anticholinergic used in nausea and vomiting |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antagonist of central/peripheral 5-HT3 on vagal afferents, NTS, postremia |  | 
        |  | 
        
        | Term 
 
        | what is the cause of post chemo nausea |  | Definition 
 
        | serotonin released by enterochromaffin cells in SI in response to chemo may stimulate vagal afferents to vomiting reflex |  | 
        |  | 
        
        | Term 
 
        | odansetron administration 4 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | most effective for chemo and upper abdominal irridation nausea effective against hyperemesis of pregnacy
 somewhat effective for post-op nausea
 |  | 
        |  | 
        
        | Term 
 
        | how is palonostron different than odansetron |  | Definition 
 
        | has t1/2 40h, longest of serotonins |  | 
        |  | 
        
        | Term 
 
        | prochlorperazine, chlorpromazine, promethazine: MOA 3 |  | Definition 
 
        | D2 antagonist at CTZ antihistamine
 anticholinergic
 |  | 
        |  | 
        
        | Term 
 
        | prochlorperazine, chlorpromazine, promethazine: use 2 |  | Definition 
 
        | most common general antinausea and antiemetic NOT effective for nausea associated with chemo
 |  | 
        |  | 
        
        | Term 
 
        | prochlorperazine, chlorpromazine, promethazine: SE |  | Definition 
 
        | most common drug to cause drowsiness |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | droperidol: administration 2 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | surgical antiemetic preop med when other tx not effective
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alters cardiac conduction sedation
 acute dystonia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stimulate ACh release from enteric neurons increasing GI motility and LES pressure (prokinetic) 
 Blocks D3 receptors at CTZ
 
 supresses inhibitor interneurons by antagonizing 5-HT3 receptor
 
 stimulates 5-HT4 receptor
 
 agonist of D2 receptors that inhibit cholinergic neurons
 |  | 
        |  | 
        
        | Term 
 
        | metoclopramide: administration 3 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | adjunct to PPI and H2 blocker for GERD 
 gastroparesis (increases gastric emptying)
 
 antinausea
 
 antiemetic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | chronic use >12wk: tarditive dyskinesia 
 acute use: acute dystonia (reversible tarditive dyskinesia) or pseudoparkinsonism EPS symptoms
 |  | 
        |  | 
        
        | Term 
 
        | MOA antihistamines for nausea and vomiting |  | Definition 
 
        | H1 antagonist on vestibular afferents in brain stem |  | 
        |  | 
        
        | Term 
 
        | use of antihistamines for nausea and vomiting |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | scopolamide: administration 2 |  | Definition 
 
        | injectable bromide transdermal patch
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prevent and tx motion sickness NO role in chemo nausea
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stimulate CB1 cannaboid receptors on neurons in vomiting center |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prophylactic for nausea in chrmo when other antiemetic uneffective 
 stimulate appetite in AIDS patients
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | central sympathomimetic activity tachycardia
 high
 |  | 
        |  | 
        
        | Term 
 
        | antiemetics used in pregnancy 3 |  | Definition 
 
        | antihistamines odanzatron
 promethazine considered
 |  | 
        |  | 
        
        | Term 
 
        | antiemetic used in severe nausea in chemo 3 |  | Definition 
 
        | metoclopramide odanzetron
 cannibis
 |  | 
        |  | 
        
        | Term 
 
        | antiemetic used in moderate emesis in chemo 3 |  | Definition 
 
        | prochlorperazine odanzetron
 dronabinol
 |  | 
        |  | 
        
        | Term 
 
        | antinausea and antiemetic used in severe chemo |  | Definition 
 
        | combinations of ones for mild and moderate symptoms |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | visceral hypersensitvity from alterations to neuroreceptor in afferent spinal neuron function 
 CNS odulation of afferent input in way that results in long term sensitization of pathways involved in visceral sensation
 
 no structural or biochemical factors
 |  | 
        |  | 
        
        | Term 
 
        | IBS associated diseases 5 |  | Definition 
 
        | depression anxiety
 chronic fatigue syndrome
 functional dyspepsia
 fibromyalgia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | lower abdominal pain constipation
 diarrhea
 bloating
 |  | 
        |  | 
        
        | Term 
 
        | tx of constipation predominate IBS 2 |  | Definition 
 
        | dietary fiber psyllium if unable to tolerate dietary fiber
 |  | 
        |  | 
        
        | Term 
 
        | DC tx of constipation predominate IBS and why, MOA, dosing |  | Definition 
 
        | tagsarod heart attacks, severe diarrhea
 12wk short term tx
 5-HT4 agonist
 |  | 
        |  | 
        
        | Term 
 
        | tx of diarrhea predominate IBS 3 |  | Definition 
 
        | psyllium ipoeramide
 avoid triggers
 |  | 
        |  | 
        
        | Term 
 
        | triggers of diarrhea predominate IBS 7 |  | Definition 
 
        | caffiene alcohol
 sweeteners: sorbitol, fructose, mannitol
 herbal medicines
 tea (senna is laxative)
 |  | 
        |  | 
        
        | Term 
 
        | tx of IBS with abdominal pain and bloating 2 and MOA |  | Definition 
 
        | antispasmotics: dicylomide
 atropine-hyoscyamide-phenobarbitol-scopolamide: anticholinergic DOC for IBS effectiveness not proven
 |  | 
        |  | 
        
        | Term 
 
        | adjnct tx for IBS 2, 2 effects |  | Definition 
 
        | TCA, SSRI help with analgesia with eating
 relieve depression
 |  | 
        |  | 
        
        | Term 
 
        | components of bile acids 3 |  | Definition 
 
        | cholic acid chenodeoxycholic acid
 deoxycholic acid
 |  | 
        |  | 
        
        | Term 
 
        | functions of bile acids 4 |  | Definition 
 
        | induce flow of bile feedback inhibition of cholesterol synthesis
 eliminate cholesterol (promote excretion)
 disperase and absorb lipids and fat soluble vitamins
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | ursodeoxycholic acid: MOA |  | Definition 
 
        | cytoprotective on hepaticytes functional gallbladder needed: modified by bile
 degrades cholesterol monohydrate crystals in 40%
 |  | 
        |  | 
        
        | Term 
 
        | ursodeoxycholic acid: use 2 |  | Definition 
 
        | cannot be used for bile acid therapy alone due to unfavorable surface area to size ratio 
 gall bladder dissolution
 
 cholestatic liver disease
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | loss of gland function (Exocrine and endocrine), inflammation, and pain |  | 
        |  | 
        
        | Term 
 
        | function of pancreatic enzymes |  | Definition 
 
        | protein and fat digestion |  | 
        |  | 
        
        | Term 
 
        | how are pancreatic enzymes released |  | Definition 
 
        | CCK releasing monitor peptide from duodenum triggers CCK then is degraded by trypsin 
 CCK stimulates release of pancreatic enzymes
 |  | 
        |  | 
        
        | Term 
 
        | effects of chronic pancreatitis on physiology |  | Definition 
 
        | trypsin insufficiency increases CCK and causes pain due to continous stimulation of enzymes and increased intraductal pressure 
 decreased digestive enzymes cases protein maldigestion and seatorrhea when >90% pancreas lost leading to malabsorption and diarrhea
 |  | 
        |  | 
        
        | Term 
 
        | goals of tx of chronic pancreatitis 2 |  | Definition 
 
        | prevention of malabsorption pain relief
 |  | 
        |  | 
        
        | Term 
 
        | 2 drugs used in chronic pancreatitis |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | delivered to duodenum during 4h period with and after a meal |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | decrease diarrhea and malabsorption due to pancreatitis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | delivered to duodenum and interrupts CCK mediated pain loop |  | 
        |  | 
        
        | Term 
 
        | why would lipase and protease be coated or uncoated |  | Definition 
 
        | coated: treat malabsorption uncoated: treat malabsorption and pain
 |  | 
        |  |